ACHV

Achieve Life Sciences, Inc. - Common Shares (ACHV)

About Achieve Life Sciences, Inc. - Common Shares (ACHV)

Achieve Life Sciences, Inc. is a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence. Its products include cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Bothell, WA.

Details

Daily high

$7.44

Daily low

$7.01

Price at open

$7.38

52 Week High

$8.64

52 Week Low

$2.62

Market cap

726.5M

Dividend yield

Volume

1.5M

Avg. volume

1.6M

P/E ratio

-4.56

Achieve Life Sciences, Inc. - Common Shares News